Target intelligence / Profile preview

C-C motif chemokine receptor-like 2 (CCRL2)

Target
CCRL2
Molecular classification
G protein-coupled receptor, Atypical chemokine receptor, Receptor
01

Overview

C-C motif chemokine receptor-like 2 (CCRL2) is an atypical, non-signaling seven-transmembrane G protein-coupled receptor that belongs to the chemokine receptor family. Unlike classical chemokine receptors, CCRL2 lacks the conserved DRYLAIV motif required for G-protein coupling and intracellular signaling. Instead, it functions primarily as a scavenger or presenting molecule, binding ligands such as CCL19 and chemerin to modulate local chemokine gradients and regulate leukocyte trafficking and immune responses. CCRL2 is highly expressed on activated myeloid cells, including neutrophils, monocytes, and dendritic cells, as well as endothelial cells.

In pathological contexts, CCRL2 is upregulated in various inflammatory conditions, such as rheumatoid arthritis, and plays complex roles in oncology. It is significantly overexpressed in high-risk myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia (AML), particularly in subtypes harboring TP53 mutations and erythroid features. Consequently, CCRL2 has emerged as a promising therapeutic target. Experimental therapies, such as anti-CCRL2 antibody-drug conjugates (ADCs) armed with cytotoxic payloads like pyrrolobenzodiazepine (PBD), have demonstrated selective cytotoxicity against TP53-mutated leukemia cells while sparing healthy hematopoietic stem cells. Additionally, blocking CCRL2-chemerin interactions is being explored to enhance anti-tumor immunity and manage inflammatory diseases.

Other names
ACKR5CKRXCRAMCRAM-ACRAM-BHCRL-CCRChemokine receptor CCR11Chemokine receptor XPutative MCP-1 chemokine receptorG protein-coupled beta chemokine receptorLipopolysaccharide-inducible C-C chemokine receptor
02

Mechanism of action

Targeted cytotoxicity via antibody-drug conjugate internalization and receptor blockade of chemokine binding

03

Biological functions

Immune responseInflammatory responseCell chemotaxisLeukocyte migrationOther
04

Disease associations

CancerInflammationInfectionNeurodegenerative diseaseOther
05

Safety considerations

NeutropeniaImpaired immune surveillanceAltered leukocyte traffickingPotential off-target myelosuppression
06

Interacting drugs

Anti-CCRL2 antibody-drug conjugate

1 more in the full profile.

07

Biomarkers

CCRL2 expressionTP53 mutationErythroid featuresCSF CCL4 levels

Beyond the preview

Go deeper on C-C motif chemokine receptor-like 2 (CCRL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-C motif chemokine receptor-like 2 (CCRL2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call